Literature DB >> 5010674

Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.

J A Romero, J P Chalmers, K Cottman, L D Lytle, R J Wurtman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5010674

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  8 in total

1.  The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.

Authors:  H Altier; M Moldes; J M Monti
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

2.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

3.  An improved fluorimetric method for assay of dopa in urine and tissues and its use for determination of urinary dopa, at endogenous level, in different species.

Authors:  J M Cottet-Emard; L Peyrin
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

4.  Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain.

Authors:  M Lindqvist; W Kehr; A Carlsson
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

5.  The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Authors:  Antti Haapalinna; Tiina Leino; Esa Heinonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

6.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.

Authors:  J M Monti
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

8.  A computational model of altered gait patterns in parkinson's disease patients negotiating narrow doorways.

Authors:  Vignesh Muralidharan; Pragathi P Balasubramani; V Srinivasa Chakravarthy; Simon J G Lewis; Ahmed A Moustafa
Journal:  Front Comput Neurosci       Date:  2014-01-09       Impact factor: 2.380
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.